Literature DB >> 2274051

Effect of 5'-flanking sequence deletions on expression of the human insulin gene in transgenic mice.

M Fromont-Racine1, D Bucchini, O Madsen, P Desbois, S Linde, J H Nielsen, C Saulnier, M A Ripoche, J Jami, R Pictet.   

Abstract

Expression of the human insulin gene was examined in transgenic mouse lines carrying the gene with various lengths of DNA sequences 5' to the transcription start site (+1). Expression of the transgene was demonstrated by 1) the presence of human C-peptide in urine, 2) the presence of specific transcripts in pancreas, but not in other tissues, 3) the specific immunofluorescence staining of pancreatic islets for human C-peptide, and 4) the synthesis and accumulation of human (pro)insulin in isolated islets. Deletions in the injected DNA fragment of sequences upstream from positions -353, -258, and -168 allowed correct initiation of the transcripts and cell specificity of expression, while quantitative expression gradually decreased. Deletion to -58 completely abolished the expression of the gene. The amount of human product that in mice harboring the longest fragment contributes up to 50% of the total insulin does not alter the normal proportion of mice insulins I and II. These results suggest that expression of the human insulin gene in vivo results from the cooperation of several cis-regulatory elements present in the various deleted fragments. With none of the deletions used, expression of the transgene was observed in cell types other than beta-islet cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2274051     DOI: 10.1210/mend-4-5-669

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  13 in total

Review 1.  Transcription of the insulin gene: towards defining the glucose-sensitive cis-element and trans-acting factors.

Authors:  D Melloul; E Cerasi
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

2.  A variant insulin promoter in non-insulin-dependent diabetes mellitus.

Authors:  L Olansky; C Welling; S Giddings; S Adler; R Bourey; G Dowse; S Serjeantson; P Zimmet; M A Permutt
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

3.  Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line.

Authors:  H Wang; P Maechler; K A Hagenfeldt; C B Wollheim
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

4.  Adaptation to supraphysiologic levels of insulin gene expression in transgenic mice: evidence for the importance of posttranscriptional regulation.

Authors:  B Schnetzler; G Murakawa; D Abalos; P Halban; R Selden
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Regulatory regions of rat insulin I gene necessary for expression in transgenic mice.

Authors:  F Dandoy-Dron; E Monthioux; J Jami; D Bucchini
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

6.  The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model.

Authors:  J L Ottesen; P Nilsson; J Jami; D Weilguny; M Dührkop; D Bucchini; S Havelund; J M Fogh
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

7.  Control of insulin gene expression by glucose.

Authors:  S Goodison; S Kenna; S J Ashcroft
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

8.  Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein STF1/IPF1 acting through the CT boxes.

Authors:  H V Petersen; P Serup; J Leonard; B K Michelsen; O D Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Isolation and characterization of a novel transcription factor that binds to and activates insulin control element-mediated expression.

Authors:  G L Robinson; S R Cordle; E Henderson; P A Weil; G Teitelman; R Stein
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

10.  Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.

Authors:  S Schinner; R Krätzner; D Baun; C Dickel; R Blume; E Oetjen
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.